Teacher Retirement System of Texas Decreases Holdings in Teladoc Inc (TDOC)

Teacher Retirement System of Texas lowered its stake in shares of Teladoc Inc (NYSE:TDOC) by 13.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,902 shares of the health services provider’s stock after selling 1,870 shares during the period. Teacher Retirement System of Texas’ holdings in Teladoc were worth $480,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. ARK Investment Management LLC lifted its stake in shares of Teladoc by 211.7% in the 4th quarter. ARK Investment Management LLC now owns 31,321 shares of the health services provider’s stock valued at $1,092,000 after purchasing an additional 21,274 shares during the last quarter. BlackRock Inc. lifted its stake in shares of Teladoc by 7.4% in the 4th quarter. BlackRock Inc. now owns 4,971,297 shares of the health services provider’s stock valued at $173,252,000 after purchasing an additional 342,715 shares during the last quarter. Monashee Investment Management LLC acquired a new stake in shares of Teladoc in the 4th quarter valued at $1,632,000. Swiss National Bank lifted its stake in shares of Teladoc by 56.0% in the 4th quarter. Swiss National Bank now owns 92,800 shares of the health services provider’s stock valued at $3,234,000 after purchasing an additional 33,300 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of Teladoc by 16.4% in the 4th quarter. Geode Capital Management LLC now owns 428,312 shares of the health services provider’s stock valued at $14,926,000 after purchasing an additional 60,205 shares during the last quarter.

In other news, VP Mark Hirschhorn sold 69,460 shares of the business’s stock in a transaction dated Wednesday, May 2nd. The shares were sold at an average price of $43.73, for a total transaction of $3,037,485.80. Following the transaction, the vice president now owns 50,042 shares in the company, valued at approximately $2,188,336.66. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Jason N. Gorevic sold 25,000 shares of the business’s stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $48.93, for a total transaction of $1,223,250.00. Following the transaction, the chief executive officer now owns 636,184 shares in the company, valued at approximately $31,128,483.12. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 119,460 shares of company stock worth $5,294,736. Insiders own 3.95% of the company’s stock.



Teladoc opened at $59.05 on Thursday, MarketBeat.com reports. Teladoc Inc has a 52-week low of $27.30 and a 52-week high of $59.75. The company has a current ratio of 4.15, a quick ratio of 4.15 and a debt-to-equity ratio of 0.38. The stock has a market cap of $3.41 billion, a PE ratio of -35.79 and a beta of 0.42.

Teladoc (NYSE:TDOC) last posted its quarterly earnings data on Tuesday, May 1st. The health services provider reported ($0.39) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.04. Teladoc had a negative net margin of 41.06% and a negative return on equity of 20.40%. The company had revenue of $89.64 million for the quarter, compared to the consensus estimate of $86.77 million. During the same quarter in the previous year, the firm posted ($0.30) EPS. The business’s revenue was up 109.0% compared to the same quarter last year. research analysts expect that Teladoc Inc will post -1.45 earnings per share for the current year.

Several research firms recently issued reports on TDOC. MED lifted their price objective on shares of Teladoc to $56.00 and gave the company a “hold” rating in a research note on Thursday, June 7th. Deutsche Bank lifted their price objective on shares of Teladoc from $45.00 to $56.00 and gave the company a “hold” rating in a research note on Thursday, June 7th. Piper Jaffray Companies lifted their price objective on shares of Teladoc to $46.00 and gave the company an “overweight” rating in a research note on Monday, June 4th. Craig Hallum upgraded shares of Teladoc from a “hold” rating to a “buy” rating in a report on Tuesday, June 5th. Finally, Canaccord Genuity lifted their target price on shares of Teladoc from $47.00 to $63.00 and gave the stock a “buy” rating in a report on Tuesday, June 5th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $49.61.

About Teladoc

Teladoc, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Institutional Ownership by Quarter for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply